Published 3 years ago

Russia files Sputnik V vaccine registration in Europe

Summary by Reuters

- Russia's sovereign wealth fund RDIF has filed for registration of the Sputnik V COVID-19 vaccine in the European Union and expects it to be reviewed in February, as Moscow seeks to speed up its availability worldwide. The official account promoting the vaccine tweeted the latest development on Wednesday, moving it a step closer for approval as countries across the world plan massive

0 Articles

All

Left

Center

Right

News18 India

Russia Files Sputnik V Covid-19 Vaccine Registration in Europe

The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews.

3 years ago·India

Read Full Article

Reuters

Russia files Sputnik V vaccine registration in Europe

3 years ago·United Kingdom

Read Full Article

The Star Kuala Lumpur

Russia files Sputnik V vaccine registration in Europe

(Reuters) - Russia's sovereign wealth fund RDIF has filed for registration of the Sputnik V COVID-19 vaccine in the European Union and expects it to be reviewed in February, as Moscow seeks to speed up its availability worldwide. Read full story

3 years ago·Malaysia

Read Full Article

TASS [🇷🇺-affiliated]

Rolling review for Sputnik V vaccine for registration in EU to commence in February

The European Agency will decide on registration of the vaccine following a series of expert checks

3 years ago·Moscow, Russian Federation

Read Full Article

National Post

Russia's foreign partners able to produce 350 mln Sputnik V doses per year

MOSCOW -- Russia's Industry Minister Denis Manturov said on Wednesday that foreign manufacturers, with whom Russia has signed deals to produce its Sputnik V COVID-19 vaccine, are capable of producing around 350 million doses per year. Read More

3 years ago·Canada

Read Full Article

Russia Today [🇷🇺-affiliated]

EU could approve Russian-made Sputnik V Covid-19 vaccine for use as early as February, amid concern over missed shipments from US

The European Medicines Agency is considering an application to approve the Sputnik V vaccine, developed by Moscow’s Gamaleya Institute, to protect the EU against coronavirus infection, the team behind the jab says.In a Tweet on Wednesday, the developers of the Russian-made formula said they had met with the European Union’s (EU) healthcare regulator just one day prior. According to the Russian Direct Investment Fund, which financed the vaccine, …

3 years ago·Russian Federation

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.